Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-14 06:11 am Sale | 2021-12-31 | 13G | 89bio, Inc. ETNB | Nussbaum Ran | 827,701 4.100% | -194,753![]() (-19.05%) | Filing History |
2022-02-14 06:08 am Unchanged | 2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Nussbaum Ran | 44,643 4.960% | 0 (Unchanged) | Filing History |
2021-02-16 11:16 am Sale | 2021-02-07 | 13G | ContextLogic Inc. LOGC | Nussbaum Ran | 50,236 4.700% | -4,333![]() (-7.94%) | Filing History |
2021-02-16 07:31 am Purchase | 2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Nussbaum Ran | 44,643 6.400% | 44,643![]() (New Position) | Filing History |
2021-02-11 08:52 am Sale | 2020-12-31 | 13G | ContextLogic Inc. LOGC | Nussbaum Ran | 54,570 5.200% | -5,279![]() (-8.82%) | Filing History |
2021-02-09 10:20 am Sale | 2020-12-31 | 13G | 89bio, Inc. ETNB | Nussbaum Ran | 1,022,454 5.100% | -112,217![]() (-9.89%) | Filing History |
2021-02-05 10:12 am Sale | 2020-12-31 | 13G | KITOV PHARMA LTD SPONSORED ADR KTOV | Nussbaum Ran | 219,306 1.300% | -4,018,830![]() (-94.83%) | Filing History |
2020-02-14 09:29 am Purchase | 2019-12-31 | 13G | 89bio, Inc. ETNB | Nussbaum Ran | 1,134,671 8.200% | 1,134,671![]() (New Position) | Filing History |
2020-02-14 06:14 am Purchase | 2019-12-31 | 13G | ContextLogic Inc. LOGC | Nussbaum Ran | 59,848 7.700% | 59,848![]() (New Position) | Filing History |
2020-02-14 06:11 am Purchase | 2019-12-31 | 13G | Enlivex Therapeutics Ltd. ENLV | Nussbaum Ran | 68,580 0.700% | 68,580![]() (New Position) | Filing History |
2020-02-13 11:23 am Purchase | 2020-01-08 | 13G | KITOV PHARMA LTD SPONSORED ADR KTOV | Nussbaum Ran | 4,238,136 13.400% | 4,238,136![]() (New Position) | Filing History |